Patients receiving compounded medication should look beyond marketing materials and inspect their actual prescription packages carefully. Professional standards leave distinct evidence directly on the physical vial and its accompanying documentation.
Legitimate compounded preparations display the specific patient name, prescribing doctor, exact compounding date, and calculated beyond-use date. The label must explicitly list the compounding pharmacy’s license number and physical street address. Never use vials that arrive without tamper-evident seals or clear storage instructions specifying whether refrigeration between 36°F and 46°F is required.
Patients should confirm that their telehealth provider provides batch lot numbers on request. If a telehealth intermediary refuses to disclose the compounding pharmacy’s identity, withholds the lot number, or cannot supply a matching Certificate of Analysis upon request, patients should pause treatment. Transparent operators like Ozari Health make this data accessible precisely because legitimate laboratories retain finished-product testing records for every distributed vial.
